Sequire Spotlight Presents First Wave BioPharma (FWBI): Clinical Stage Biopharmaceuticals

Host Carmel Fisher interviews President & CEO, James Sapirstein. He talks about how the company has been cutting costs to stay in compliance with Nasdaq and the biopharmacuetical market.